David A. Siegel Rani Therapeutics Holdings, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 110,163 shares of RANI stock, worth $185,073. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110,163Holding current value
$185,073% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RANI
# of Institutions
47Shares Held
3.68MCall Options Held
44KPut Options Held
193K-
Vanguard Group Inc Valley Forge, PA710KShares$1.19 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$829,2210.67% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$753,4660.04% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$508,6080.01% of portfolio
-
Two Sigma Investments, LP New York, NY291KShares$489,5200.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $41.1M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...